MSA Advisors’s Lunai Bioworks LNAI Stock Holding History

MSA Advisors’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-313	Closed	-$13.6K	–	32
2025 Q1	$13.6K	Hold	313	–	–	﹤0.01%	30
2024 Q4	$20.9K	Hold	313	–	–	0.01%	31
2024 Q3	$12.1K	Hold	313	–	–	﹤0.01%	29
2024 Q2	$43.8K	Hold	313	–	–	0.01%	26
2024 Q1	$66.3K	Hold	313	–	–	0.02%	23
2023 Q4	$79.3K	Buy	+313	New	+$85.8K	0.03%	20

Other funds holding LNAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

MSA Advisors's LNAI Position: Q2 2025 in Review

MSA Advisors sold out of Lunai Bioworks (LNAI) in Q2 2025, closing a stake of 313 shares — an estimated $13.6K sold.

MSA Advisors first reported a position in LNAI in Q4 2023 and held it in 6 quarters. The position peaked at $79.3K in Q4 2023. 42 funds tracked by Wall St. Rank hold LNAI as of Q2 2025.

MSA Advisors reported no remaining Lunai Bioworks position as of Q2 2025 after selling out during the quarter.
MSA Advisors sold 313 Lunai Bioworks shares in Q2 2025, an estimated $13.6K.
MSA Advisors first reported a position in Lunai Bioworks in Q4 2023 and held it in 6 quarters.
MSA Advisors's Lunai Bioworks position peaked at $79.3K in Q4 2023.
42 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2025.

Based on MSA Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.